secwatch.observer — SEC 8-K summary
======================================

Issuer:     Renalytix plc (RNLXY)
CIK:        0001811115
Form:       8-K
Filed at:   2023-07-17T23:59:59+00:00
Accession:  0000950170-23-033233
Event type: debt
Sentiment:  neutral
Materiality: 0.25
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Renalytix repays $1.06M of convertible bond via ADS issuance; principal reduced to $15.9M
--------------------------------------------------------------------------------

- Repaid $1.06M of convertible bond by issuing 526,211 American Depositary Shares (1,052,422 ordinary shares).
- Remaining principal under the convertible bond after settlement is $15.90M.
- New ordinary shares admitted to trading on AIM effective July 19, 2023.
- Post-admission total ordinary shares outstanding: 94,833,900.
- Announcement corrects prior figure for principal remaining from earlier release.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1811115/000095017023033233/0000950170-23-033233-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1811115/000095017023033233/rnlx-20230717.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-033233

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer